Please login to the form below

Not currently logged in
Email:
Password:

INC Research acquires Middle Eastern CRO

Purchase of MEK Consulting expands its geographic footprint

INC Research has expanded its geographic footprint across the Middle East, north Africa and southern Europe by acquiring Lebanon-based contract research organisation (CRO) MEK Consulting.

MEK, which also has offices in Greece and Turkey, is a clinical monitoring-focused CRO with more than 40 employees.

INC chief executive Jamie Macdonald said: "The Middle East and north Africa region offers significant opportunities for new drug development due to its large patient populations, highly qualified medical personnel and increasingly sophisticated regulatory environments.

"The acquisition of MEK Consulting provides INC Research's customers with access to this expanding region for biopharmaceutical development and further demonstrates our commitment to connect them to everything they need to conduct their trials."

MEK will now operate under the INC Research name but it will continue to be led by founders Myriam El-Khazen and Selim Dagher, who become general manager and executive director, commercial operations, respectively.

Myriam El-Khazen said: "We believe this acquisition will bring the MENA region and southern Europe to a new era in clinical research. This will be advantageous for our customers, the patients in the region and our company.”

7th March 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics